Sickle Cell Disease

Sickle Cell Disease is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or .

The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:

-- The first section of this topic is shown below --

General Principles

  • SCD is a group of hereditary Hgb disorders in which Hgb undergoes a sickle shape transformation under conditions of deoxygenation.
  • The most common are homozygous sickle cell anemia (Hgb SS) or other double-heterozygous conditions (Hgb SC, Hgb S–β°, or Hgb S–β+ thalassemia).
  • Newborn-screening programs for hemoglobinopathies are available throughout the United States and identify most patients in infancy.
  • In the United States, the incidence of SCD is approximately 1 in 625 births.
  • Sickle cell trait is present in 7%–8% of African Americans. It is generally considered to be a benign carrier state, but high-altitude hypoxia is associated with splenic infarction, whereas intense physical exertion has been associated with sudden death and rhabdomyolysis.1
  • Sickle cell trait has been associated with an increased risk of pulmonary embolism, proteinuria, and CKD. Minimizing other risk factors for kidney disease is likely to benefit patients at risk.2

-- To view the remaining sections of this topic, please or --

General Principles

  • SCD is a group of hereditary Hgb disorders in which Hgb undergoes a sickle shape transformation under conditions of deoxygenation.
  • The most common are homozygous sickle cell anemia (Hgb SS) or other double-heterozygous conditions (Hgb SC, Hgb S–β°, or Hgb S–β+ thalassemia).
  • Newborn-screening programs for hemoglobinopathies are available throughout the United States and identify most patients in infancy.
  • In the United States, the incidence of SCD is approximately 1 in 625 births.
  • Sickle cell trait is present in 7%–8% of African Americans. It is generally considered to be a benign carrier state, but high-altitude hypoxia is associated with splenic infarction, whereas intense physical exertion has been associated with sudden death and rhabdomyolysis.1
  • Sickle cell trait has been associated with an increased risk of pulmonary embolism, proteinuria, and CKD. Minimizing other risk factors for kidney disease is likely to benefit patients at risk.2

There's more to see -- the rest of this entry is available only to subscribers.